People · Operator
Named in public records as an officer, director or promoter · active 2023–2025 · Pharmaceuticals, Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| SciSparc Ltd. | — | Pharmaceuticals | Series A | $25.3M | $16.1M | 2023 |
| Clearmind Medicine Inc. | — | Biotechnology | Seed | $2.4M | $15.1M | 2024 |
Dr. Adi Zuloff-Shani at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Dr. Adi Zuloff-Shani on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Amitay Weiss | 2 | 6 |
| Oz Adler | 2 | 4 |
| Eric So | 1 | 5 |
| Moshe Revach | 1 | 3 |
| Asaf Itzhaik | 1 | 2 |
| Alan Rootenberg | 1 | 2 |
| Zohar Heiblum | 1 | 2 |
| Alon Dayan | 1 | 2 |
| Ascher Shmulewitz | 1 | 2 |
| Stephen Simes | 1 | 2 |
| Yehonatan Shachar | 1 | 2 |
| Prof. Mark Haden | 1 | 1 |
| Itschak Shrem | 1 | 1 |
| Lior Vider | 1 | 1 |
| Amnon Ben Shay | 1 | 1 |
| Liat Sidi | 1 | 1 |
| Adi Zuloff-Shani | 1 | 1 |
| Amit Berger | 1 | 1 |
| Yafit Stark | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.